Compounds > adenine

adenine and valproic acid

adenine has been researched along with valproic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Cai, Y; Dai, XY; Guan, QC; Guan, Y; Kong, W; Wang, X; Xu, MJ; Zhao, MM; Zhao, Y; Zhu, WG1
Doi, S; Doi, T; Kawaoka, K; Masaki, T; Nakashima, A; Ueno, T; Yamada, K1
Li, XX; Weng, LH; Wu, JY; Xu, Y; Yu, LJ; Zhang, Y1

Other Studies

6 other study(ies) available for adenine and valproic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release.
    Kidney international, 2013, Volume: 83, Issue:6

    Topics: Adenine; Alkaline Phosphatase; Amino Acid Chloromethyl Ketones; Animals; Antioxidants; Autophagy; Autophagy-Related Protein 5; Caspase Inhibitors; Cattle; Cells, Cultured; Disease Models, Animal; Kidney Failure, Chronic; Metalloporphyrins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphates; Proteins; Rats; RNA Interference; Secretory Vesicles; Sodium-Phosphate Cotransporter Proteins, Type III; Superoxide Dismutase; Time Factors; Transfection; Valproic Acid; Vascular Calcification

2013
Valproic acid attenuates renal fibrosis through the induction of autophagy.
    Clinical and experimental nephrology, 2017, Volume: 21, Issue:5

    Topics: Actins; Adenine; Animals; Autophagy; Cell Line; Collagen Type I; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblasts; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Microtubule-Associated Proteins; Rats; Transforming Growth Factor beta1; Ureteral Obstruction; Valproic Acid

2017
Valproic acid protects against MPP
    Neuroscience letters, 2017, 01-18, Volume: 638

    Topics: 1-Methyl-4-phenylpyridinium; Adenine; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Humans; Macrolides; Mitochondria; Neuroprotective Agents; Parkinson Disease; Reactive Oxygen Species; Valproic Acid

2017